Please find attached the unaudited financial results for the quarter ended June 30, 2026

Registered Office: “THIRUMALAI HOUSE”, Plot No. 101-102, Road No. 29, Sion (East), Mumbai – 400 022, India PHONE: +91 – 22– 43686200 FAX +91 – 22 – 24011699 E- MAIL: thirumalai@thirumalaichemicals.com Website: www.thirumalaichemicals.com (AN ISO 9001, 14001, 50001/ HACCP & FSSC 22000 CERTIFIED COMPANY) CIN: L24100MH1972PLC016149 TCL/SE025/2026-27 August 04, 2026 The National Stock Exchange of India Limited BSE Limited Listing Department Department of Corporate Services Exchange Plaza, Bandra Kurla Complex Floor 25, Phiroze Jeejeebhoy Towers Bandra (East) Dalal Street Mumbai 400 051 Mumbai 400 001 Scrip code: TIRUMALCHM Scrip code: 500412 Dear Sir/ Madam, Sub.: Outcome of the Board Meeting and Disclosures under Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR') In compliance with the provisions of Regulation 30 and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, we wish to inform you that the Board of Directors of the Company at its meeting held on Tuesday, August 04, 2026, (i.e., today) have inter-alia considered and approved the following: 1. Financials Results Un-audited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2026, The copies of aforesaid Financial Results along with the Limited Review Reports from the Statutory Auditors of the Company are enclosed herewith as Annexure A. 2. Raising of Funds The Board has considered and approved raising of funds for an amount aggregating up to Rs. 750 crores, inter alia, by way of debt and/or issuance of equity shares, fully/partly convertible debentures, non-convertible debentures,, and/or any other financial instruments (including warrants) / securities convertible into equity shares, and/ or combination of any of the aforementioned through public offer and/ or private placement including by way of a qualified institutions placement in accordance with Chapter VI of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, preferential issue, rights issue and / or through any other permissible mode, as may be permitted under applicable laws to eligible investors, subject to approval of shareholders of the Company required if any and such regulatory/statutory approvals as may be required. The proceeds from the aforesaid proposed fund raising are intended to be utilised as may be eventually decided by the Board for, among other things, day to day operations and refinance/repayment of existing debts of the Company. The details of fund raise are provided in Annexure B. Registered Office: “THIRUMALAI HOUSE”, Plot No. 101-102, Road No. 29, Sion (East), Mumbai – 400 022, India PHONE: +91 – 22– 43686200 FAX +91 – 22 – 24011699 E-MAIL: thirumalai@thirumalaichemicals.com Website: www.thirumalaichemicals.com (AN ISO 9001, 14001, 50001/ HACCP & FSSC 22000 CERTIFIED COMPANY) CIN: L24100MH1972PLC016149 3. Sale of Wind Energy based Electric Power Generator Owned by the Company (Windmill) The Board has approved the sale of four windmills owned by the Company having an installed capacity of 3.2 MW, standing on separate parcels of land measuring 11.42 acres in Muthunaickenpatti, Dindigul District, Tamil Nadu. The details of transaction are provided in Annexure B. The information is also being made available on the website of the company at https://thirumalaichemicals.com. The Board meeting commended at 09.30 a.m. and concluded at 03:50 p.m. Kindly take the above information into your records. Thanking you, Yours faithfully, For Thirumalai Chemicals Limited Aditya Sharma Company Secretary & Compliance officer ANNEXURE -A - Un-Audited Financial Results Walker Chandiok & Co LLP 11th floor, A wing, Prestige Polygon, 471 Anna Salai, Teynampet, Chennai - 600 035 Tamil Nadu, India T +91 44 4294 0099 F +91 44 4294 0044 Independent Auditor’s Review Report on Standalone Unaudited Quarterly Financial Results of the Company pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) To the Board of Directors of Thirumalai Chemicals Limited 1. We have reviewed the accompanying statement of standalone unaudited financial results (‘the Statement’) of Thirumalai Chemicals Limited (‘the Company’) for the quarter ended 30 June 2026, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) (‘Listing Regulations’) 2. The Statement, which is the responsibility of the Company’s management and approved by the Company’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, Interim Financial Reporting (‘Ind AS 34’), prescribed under section 133 of the Companies Act, 2013 (‘the Act’), and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, Review of Interim Financial Information Performed by the Independent Auditor of the Entity, issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with the Standards on Auditing specified under section 143(10) of the Act, and consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. Chartered Accountants Walker Chandiok & Co LLP is registered with limited liability with identification number Offices in Ahmedabad, Bengaluru, Chandigarh, Chennai, Dehradun, Goa, Gurugram, Hyderabad, Kochi, AAC-2085 and has its registered office at L- Kolkata, Mumbai, New Delhi, Noida and Pune 41, Connaught Circus, Outer Circle, New Delhi, 110001, India 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in Ind AS 34, prescribed under section 133 of the Act, and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in accordance with the requirements of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. For Walker Chandiok & Co LLP Chartered Accountants Firm Registration No: 001076N/N500013 Vijay Vikram Singh Partner Membership No. 059139 UDIN: 26059139DQMAVH5610 Bengaluru 04 August 2026 Walker Chandiok & Co LLP 11th floor, A wing, Prestige Polygon, 471 Anna Salai, Teynampet, Chennai - 600 035 Tamil Nadu, India T +91 44 4294 0099 F +91 44 4294 0044 Independent Auditor’s Review Report on Consolidated Unaudited Quarterly Financial Results of the Company pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) To the Board of Directors of Thirumalai Chemicals Limited 1. We have reviewed the accompanying statement of unaudited consolidated financial results (‘the Statement’) of Thirumalai Chemicals Limited (‘the Holding Company’) and its subsidiaries (the Holding Company and its subsidiaries together referred to as ‘the Group’), (refer Annexure 1 for the list of subsidiaries, included in the Statement) for the quarter ended 30 June 2026, being submitted by the Holdin [Showing first 8,000 characters — download PDF for full document]